Elliptical excimer laser PK improves vision

Article

Elliptical excimer laser penetrating keratoplasty (EELPK) is an effective method of improving visual acuity.

Elliptical excimer laser penetrating keratoplasty (EELPK) is an effective method of improving visual acuity (VA), according to a report published in the November 2007 issue of Current Eye Research.

Nora Szentmary from the Friedrich Alexander University, Erlangen and colleagues from various centres across Germany and Hungary assessed the long-term refractive and visual outcomes of EELPK. The study included 17 phakic eyes, six of which underwent simultaneous cataract surgery.

Best corrected visual acuity (BCVA) improved from 0.2 preoperatively, to 0.65 following suture removal (p<0.001). After suture removal, keratometric and refractive cylinder increased and surface regularity index and surface asymmetry index decreased significantly (p=0.01).

This study suggests that EELPK can be an effective method of improving VA.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.